Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from 'Immunotherapy Bridge'.
Merkel cell carcinoma
basal cell carcinoma
cutaneous immunotherapy
nonmelanoma skin cancer
squamous cell carcinoma
Journal
Immunotherapy
ISSN: 1750-7448
Titre abrégé: Immunotherapy
Pays: England
ID NLM: 101485158
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
27
3
2020
medline:
6
5
2021
entrez:
27
3
2020
Statut:
ppublish
Résumé
Over the last few years, extensive research has improved our understanding of tumor immunology and has enabled the development of novel treatments. The state of the art of immunotherapy in various types of malignancies was exhaustively discussed in the 'Immunotherapy Bridge' meeting, which was held in Naples on 4-5 December 2019. Highlights related to the immunological treatment of nonmelanoma skin cancer are the content of this article.
Identifiants
pubmed: 32208790
doi: 10.2217/imt-2020-0042
doi:
Substances chimiques
Antineoplastic Agents, Immunological
0
Types de publication
Congress
Langues
eng
Sous-ensembles de citation
IM